MedTrace Logo

Transnasal Sphenopalatine Ganglion Block for Postoperative Pain and Recovery in Tonsillectomy (TONwoPA)

NCT07370129 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2026-01-27

No results posted yet for this study

Summary

The aim of this clinical trial is to evaluate the effectiveness of transnasal transmucosal sphenopalatine ganglion block in reducing post-tonsillectomy pain. The study also investigates its impact on rescue analgesic requirements and postoperative recovery by comparing 5% lidocaine with placebo.

Participants will receive a transnasal transmucosal sphenopalatine ganglion block with either 5% lidocaine or placebo (saline). Postoperative pain levels and opioid consumption will be monitored during the first 24 hours after surgery. In addition, length of hospital stay, the occurrence of primary and secondary post-tonsillectomy hemorrhage up to 14 days, unplanned hospital readmissions after discharge, and patient satisfaction on postoperative day 14 will be assessed.

Conditions

  • Post Tonsillectomy Pain
  • Post Operative Analgesia
  • Opioid Consumption
  • Sphenopalatine Ganglion Block
  • Tonsillar Surgery Complications

Interventions

PROCEDURE

Transnasal Transmucosal Sphenopalatine Ganglion Block

Before the start of surgery, a preemptive transnasal transmucosal sphenopalatine ganglion block will be performed using cotton-tipped applicators. The assigned solutions will be administered via the applicators according to group allocation.

PROCEDURE

Lidocaine %5

Transnasal Transmucosal Sphenopalatine Ganglion Block with Lidocaine %5

PROCEDURE

Saline (0.9% NaCl)

Transnasal Transmucosal Sphenopalatine Ganglion Block with Saline (0.9% NaCl)

Sponsors & Collaborators

  • Ankara University

    lead OTHER

Principal Investigators

  • İbrahim Aşık, Professor · Ankara University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-01
Primary Completion
2026-06-01
Completion
2026-06-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07370129 on ClinicalTrials.gov